IMMUNE PROFILING OF TESTICULAR GERM CELL TUMORS REVEALS HIGH EXPRESSION OF PD-L1 AND PD-1

被引：1
作者：
Taheri, Diana
Rodriguez, Maria A. Mendoza
Chaux, Alcides
Drake, Charles
Bivalacqua, Trinity J.
Meeker, Alan
Taube, Janis
Gonzalez-Roibon, Nilda
Nelson, William
Yegnasubramanian, Sirinivasan
Netto, George
Haffner, Michael
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.993
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD34-08
引用
收藏
页码：E841 / E842
页数：2
相关论文
共 50 条
  • [41] Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors
    Al-Hogbani, Mofarej
    Duguay, Jeremie
    Wagner, Daniel-Christoph
    Haferkamp, Axel
    Joubert, Philippe
    Frees, Sebastian
    Rendon, Ricardo
    Power, Nicholas
    Perigny, Martine
    Toren, Paul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (05) : 303.e1 - 303.e8
  • [42] PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
    Huang, Changsheng
    Ren, Shengxiang
    Chen, Yaqi
    Liu, Anyi
    Wu, Qi
    Jiang, Tao
    Lv, Panjing
    Song, Da
    Hu, Fuqing
    Lan, Jingqing
    Sun, Li
    Zheng, Xue
    Luo, Xuelai
    Chu, Qian
    Jia, Keyi
    Li, Yan
    Wang, Jun
    Zou, Caicun
    Hu, Junbo
    Wang, Guihua
    SCIENCE ADVANCES, 2023, 9 (21)
  • [43] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [44] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [45] PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
    Tang, Quanying
    Zhao, Shikang
    Zhou, Ning
    He, Jinling
    Zu, Lingling
    Liu, Tingwen
    Song, Zuoqing
    Chen, Jun
    Peng, Ling
    Xu, Song
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (04)
  • [46] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [47] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [48] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [49] PD-1 and PD-L1 expression in pulmonary carcinoid tumours
    Vesterinen, T.
    Kuopio, T.
    Ahtiainen, M.
    Knuuttila, A.
    Salmenkivi, K.
    Mustonen, H.
    Arola, J.
    Haglund, C.
    VIRCHOWS ARCHIV, 2019, 475 : S227 - S227
  • [50] Expression of PD-1 and PD-L1 in thymic epithelial neoplasms
    Weissferdt, Annikka
    Fujimoto, Junya
    Kalhor, Neda
    Rodriguez, Jaime
    Bassett, Roland
    Wistuba, Ignacio I.
    Moran, Cesar A.
    MODERN PATHOLOGY, 2017, 30 (06) : 826 - 833
12345